Guihai Ai

803 total citations
19 papers, 573 citations indexed

About

Guihai Ai is a scholar working on Molecular Biology, Cancer Research and Obstetrics and Gynecology. According to data from OpenAlex, Guihai Ai has authored 19 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Obstetrics and Gynecology. Recurrent topics in Guihai Ai's work include MicroRNA in disease regulation (5 papers), Uterine Myomas and Treatments (5 papers) and Endometriosis Research and Treatment (5 papers). Guihai Ai is often cited by papers focused on MicroRNA in disease regulation (5 papers), Uterine Myomas and Treatments (5 papers) and Endometriosis Research and Treatment (5 papers). Guihai Ai collaborates with scholars based in China and Malaysia. Guihai Ai's co-authors include Zhongping Cheng, Jing Guo, Huan Li, Mengmeng Chen, Jianhong Zhou, Weipu Mao, Ning Luo, Li Liu, Caixia Li and Jie Liu and has published in prestigious journals such as Journal of Clinical Oncology, Medicine and Oncotarget.

In The Last Decade

Guihai Ai

19 papers receiving 567 citations

Peers

Guihai Ai
Comparison fields: 5 of 72
  • Molecular Biology 344
  • Cancer Research 227
  • Immunology 69
  • Oncology 64
  • Pharmacology 59
Replace Samina Dongol with:
Samina Dongol China
Igor Hrgović Germany
Shuo Liang China
Tatsuhiko Shigeto Japan
Chong Lu China
Zhaoying Yang China
Ranadip Mandal Germany
Zhiqin Fu China
Bingyu Wang China
Samina Dongol China View profile →
Citations per field, relative to Guihai Ai
Guihai Ai · 1×
Citations per year, relative to Guihai Ai
Guihai Ai · 1×

Countries citing papers authored by Guihai Ai

Since Specialization
Citations

This map shows the geographic impact of Guihai Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guihai Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guihai Ai more than expected).

Fields of papers citing papers by Guihai Ai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guihai Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guihai Ai. The network helps show where Guihai Ai may publish in the future.

Co-authorship network of co-authors of Guihai Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Guihai Ai. A scholar is included among the top collaborators of Guihai Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guihai Ai. Guihai Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
# Work Indexed citations
1 3
2 4
3 2
4 21
5 43
6 2
7 9
8 26
9 3
10 7
11 11
12 45
13 74
14 5
15 102
16
microRNA-196a promotes osteogenic differentiation and inhibit adipogenic differentiation of adipose stem cells via regulating β-catenin pathway.
11
17 160
18 28
19 17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026